BlackRock Inc. Purchases New Holdings in Chemed Corporation $CHE

Key Points

• BlackRock acquired 1.48 million Chemed shares in the second quarter, worth approximately $691.3 million, giving it an 11.36% stake. Institutional investors collectively own 95.85% of the company.
• Chemed exceeded quarterly expectations, reporting $6.06 in EPS and $673.25 million in revenue, with revenue rising 8.8% year over year. The company issued fiscal 2026 EPS guidance of $25.00–$25.75.
• Chemed raised its quarterly dividend from $0.60 to $0.70 per share, equivalent to a $2.80 annualized payout and a 0.5% yield. Analysts remain mostly neutral, with a consensus “Hold” rating and a $530.75 target price.

BlackRock Inc. bought a new position in Chemed Corporation (NYSE:CHE - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,484,282 shares of the company's stock, valued at approximately $691,290,000. BlackRock Inc. owned 11.36% of Chemed as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the stock. Monetary Solutions Ltd acquired a new position in shares of Chemed in the fourth quarter worth $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed during the fourth quarter valued at approximately $26,000. BOK Financial Private Wealth Inc. bought a new position in Chemed in the 4th quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Chemed in the second quarter worth about $34,000. Finally, Versant Capital Management Inc lifted its holdings in shares of Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company's stock worth $35,000 after buying an additional 75 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Price Performance

Shares of CHE stock opened at $541.33 on Monday. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $557.00. The company has a market capitalization of $7.08 billion, a P/E ratio of 27.19, a P/E/G ratio of 2.05 and a beta of 0.51. The stock has a 50 day moving average of $499.24 and a two-hundred day moving average of $446.50. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.60 by $0.46. The business had revenue of $673.25 million for the quarter, compared to analysts' expectations of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.Chemed's quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the business posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. As a group, equities analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be issued a $0.70 dividend. This is a boost from Chemed's previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. Chemed's payout ratio is presently 14.06%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on CHE. Royal Bank Of Canada increased their price objective on Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a research report on Thursday, July 30th. Bank of America reiterated a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Wall Street Zen raised shares of Chemed from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 1st. Zacks Research upgraded shares of Chemed from a "strong sell" rating to a "hold" rating in a research report on Monday, April 27th. Finally, Weiss Ratings upgraded shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $530.75.

Insider Buying and Selling at Chemed

In other news, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the sale, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. The trade was a 22.73% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the sale, the director owned 3,533 shares in the company, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,537 shares of company stock valued at $1,782,654 in the last 90 days. 3.33% of the stock is currently owned by company insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source